Journal September 19, 2026 5 min read

How to verify Kisspeptin-10 purity and batch documentation

Kisspeptin-10 is a decapeptide agonist of the KISS1R receptor. This article outlines how to verify its purity and batch documentation, and reviews key research findings from animal and in vitro studies.

peptides-pro Editorial

Kisspeptin-10 (Kp10), also known as metastin 45-54 or kisspeptin-54 (45-54), is a decapeptide fragment of the larger kisspeptin-54 protein. Its sequence is Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2, with a molecular weight of approximately 1302.5 Da. As a research compound, it is supplied as a lyophilized powder and is intended for laboratory use only. The work described here centres on the KISS1R receptor (formerly GPR54), a G protein-coupled receptor that mediates kisspeptin signalling.

Verifying purity and batch documentation for Kisspeptin-10 involves confirming the compound's identity, purity, and the presence of a certificate of analysis (CoA) that reports these parameters. Researchers should request a CoA that includes high-performance liquid chromatography (HPLC) data, mass spectrometry (MS) results, and peptide content. The CoA should also state the batch number, date of manufacture, and storage conditions. Without such documentation, experimental reproducibility is compromised.

Research Studies

Kisspeptin-10 and fetal cardiac programming in maternal hypothyroidism

In a study using Wistar rats, maternal hypothyroidism (MH) was induced with propylthiouracil (PTU), and Kisspeptin-10 was administered from gestational day 8. Offspring hearts were analysed at fetal day 18 and postnatal days 3 and 21. MH reduced fetal and postnatal body and heart mass, and Kisspeptin-10 treatment partially rescued these parameters [1]. This suggests a potential role for Kisspeptin-10 in fetal cardiac development, though the findings are animal-only and cannot be extrapolated to humans.

Kisspeptin-10 and gonadotropin secretion in healthy men

A randomized, single-blinded, placebo-controlled study evaluated acute and chronic subcutaneous Kisspeptin-10 administration in healthy men. The study characterized the acute dose-response relationship, assessed continuous infusion over 5 days, and daily intermittent administration (8 h on, 16 h off) for 12 days. Chronic subcutaneous Kisspeptin-10 stimulated gonadotropin secretion for 12 days [2]. This human study provides data on the endocrine effects of Kisspeptin-10, but it does not address purity or batch documentation.

Kisspeptin-10 and tachyphylaxis in vitro

In HEK293 cells, the kisspeptin analog C6 elicited greater tachyphylaxis and transcriptional activation than Kisspeptin-10 and Kisspeptin-54. Direct comparative data on the pharmacological profiles of these molecules remain limited [3]. This in vitro study highlights the importance of using well-characterized compounds to ensure reproducible results.

Kisspeptin-10 and glycosaminoglycan content in human cardiac fibroblasts

In human cardiac fibroblast cultures, Kisspeptin-10 (KiSS-10) was found to regulate glycosaminoglycan and decorin content. The study identified a mechanism involving signalling inhibitors [4]. This in vitro work suggests a role for Kisspeptin-10 in extracellular matrix remodelling, but it is not a purity verification study.

Kisspeptin-10 and puberty in ewes

In ewe lambs, changes in Kisspeptin-10, neurokinin B, and dynorphin A concentrations were measured in blood plasma during puberty. The study examined the relationship between these neuropeptides and the time of first ovulation [5]. This animal study provides insights into the neuroendocrine regulation of puberty but does not address batch documentation.

Kisspeptin-10 and obesity-diabetes in high-fat fed female mice

In high-fat diet-fed female mice, twice-daily intraperitoneal administration of Kisspeptin-10 (25 nmol/kg) for 21 days decreased body weight, blood glucose, and energy intake to levels seen in normal diet mice. It also affected circulating follicle-stimulating hormone (FSH) levels and the morphology of ileal enteroendocrine and pancreatic islet cells [6]. This animal study demonstrates metabolic effects of Kisspeptin-10 but is not relevant to purity verification.

Kisspeptin-10 and LH secretion in healthy men

In three healthy adult men, continuous intravenous infusion of Kisspeptin-10 at 12.5 mcg/kg/h for 24 h was used to examine the effects on luteinizing hormone (LH) secretion. The study aimed to replicate findings from non-human primates [7]. This human study provides data on the dynamic modulation of LH secretion but does not address purity or batch documentation.

Kisspeptin-10 and human placentation

A review of the KISS1/KISS1R axis in human placentation discusses molecular mechanisms and implications for foetal growth restriction and pre-eclampsia. It highlights the potential of kisspeptin as a biomarker for placental dysfunction [8]. This review is not a primary study and does not provide purity data.

Kisspeptin-10 and structural selectivity for KISS1R

Computational studies have provided insights into the structural basis for Kisspeptin-10 selectivity toward KISS1R. Kisspeptin-10 is the bioactive core fragment of kisspeptin neuropeptides and has been implicated in reward-related behaviours beyond reproductive neuroendocrinology [9]. This reference-only item supports the understanding of Kisspeptin-10's mechanism but does not address purity verification.

Kisspeptin-10 and central precocious puberty diagnosis

The ratio of Kisspeptin-10 to basal LH has been studied to improve the differentiation of central precocious puberty and premature thelarche. Kisspeptin-10, neurokinin B, and neuropeptide Y are key regulators of GnRH secretion and may serve as surrogate biomarkers [10]. This reference-only item is clinical in nature and not relevant to purity verification.

Kisspeptin-10 and ovarian cancer progression

Exogenous Kisspeptin-10 has been shown to inhibit ovarian cancer progression through targeting the SP1-hTERT-ZEB1 regulatory axis in SKOV-3 ovarian cancer cell lines using in vitro and computational methods [11]. This reference-only item is not relevant to purity verification.

Kisspeptin-10 and ovarian follicle development in mice

In mice, Kisspeptin-10 promotes hormone secretion, ovarian follicle development, and fecundity via the PI3K/AKT/ERK signalling pathway. Follicular granulosa cells were cultured in EMDM/F12 medium [12]. This reference-only item is not relevant to purity verification.

If you are reading this for personal health reasons

This material is sold for laboratory research only. We do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.